EndoStim Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:EndoStim Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10396
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EndoStim Inc (EndoStim) is a medical device company that provides therapeutic solutions. The company develops and commercializes a neurostimulation system for the treatment of severe gastroesophageal reflux disease. It concentrates on the treatment of gastroesophageal reflux disease through electrical stimulation. EndoStim also conducts clinical research for various drugs. The company conducts research on common symptoms and causes of gastroesophageal reflux disease, among others. It markets its products in domestic and international healthcare markets through its network of distributors. EndoStim is headquartered in Dallas, Texas, the US.

EndoStim Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EndoStim Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EndoStim Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EndoStim Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EndoStim Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
EndoStim Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EndoStim Inc, Medical Equipment, Deal Details 10
Venture Financing 10
EndoStim Raises USD12.1 Million in Venture Financing 10
EndoStim Raises USD25 Million in Series D Financing 11
EndoStim Raises USD11 Million in Venture Financing 12
EndoStim Raises USD2.5 Million in Venture Financing 13
EndoStim Raises US$14 Million In Venture Financing 14
Equity Offering 15
EndoStim Withdraws IPO for up to USD38.4 Million 15
EndoStim Inc – Key Competitors 16
EndoStim Inc – Key Employees 17
EndoStim Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
EndoStim Inc, Medical Equipment, Key Facts 2
EndoStim Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
EndoStim Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EndoStim Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EndoStim Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EndoStim Inc, Deals By Market, 2012 to YTD 2018 8
EndoStim Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EndoStim Raises USD12.1 Million in Venture Financing 10
EndoStim Raises USD25 Million in Series D Financing 11
EndoStim Raises USD11 Million in Venture Financing 12
EndoStim Raises USD2.5 Million in Venture Financing 13
EndoStim Raises US$14 Million In Venture Financing 14
EndoStim Withdraws IPO for up to USD38.4 Million 15
EndoStim Inc, Key Competitors 16
EndoStim Inc, Key Employees 17
EndoStim Inc, Other Locations 18

List of Figures
EndoStim Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
EndoStim Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
EndoStim Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
EndoStim Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
EndoStim Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EndoStim Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
EndoStim Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EndoStim Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[EndoStim Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Synergy Pharmaceuticals Inc:企業の戦略的SWOT分析
    Synergy Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Choppies Enterprises Limited:企業の戦略的SWOT分析
    Choppies Enterprises Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Suzuki Motor Corporation (7269):企業の財務・戦略的SWOT分析
    Suzuki Motor Corporation (7269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析
    The Ensign Group Inc (ENSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Mitsubishi Research Institute Inc (3636):企業の財務・戦略的SWOT分析
    Mitsubishi Research Institute Inc (3636) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Bauer AG (B5A)
    Bauer AG (B5A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Centrexion Therapeutics Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Centrexion Therapeutics Corp (Centrexion Therapeutics), formerly Centrexion Corp is a developer of clinical pipelines of novel and non opioid chronic pain therapy products. The company offers products such as CNTX-4975, CNTX- 0290, CNTX-6970, CNTX-2022, CNTX-6016 and Intrathecalplatform. Its …
  • Aduro BioTech Inc (ADRO):企業の財務・戦略的SWOT分析
    Summary Aduro BioTech Inc (Aduro BioTech) is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sti …
  • Norwest Venture Partners XII, LP:企業のM&A・事業提携・投資動向
    Norwest Venture Partners XII, LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norwest Venture Partners XII, LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Geisinger Health System-医療機器分野:企業M&A・提携分析
    Summary Geisinger Health System (GHS) is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers a range of medical services for patients suffering from diseases related to cardiology, ENT, gastroenterology …
  • Hammerson plc:企業のM&A・事業提携・投資動向
    Hammerson plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hammerson plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Oxford Gene Technology Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford Gene Technology Ltd (OGT) is a provider of genetics research solutions. The company’s products comprise fish probes, custom cancer panels, custom AML panel, custom breast cancer panel, custom FH panel, core MPN panel, ovarian cancer panel, myeloid panel and others. It provides medical …
  • Owens & Minor, Inc.:企業の戦略・SWOT・財務情報
    Owens & Minor, Inc. - Strategy, SWOT and Corporate Finance Report Summary Owens & Minor, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Elizabeth Arden, Inc. (RDEN):企業の財務・戦略的SWOT分析
    Elizabeth Arden, Inc. (RDEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Genovis AB (GENO):製薬・医療:M&Aディール及び事業提携情報
    Summary Genovis AB (Genovis) develops, produces and markets enzyme products, which facilitate the development and quality control of biological drugs. The company’s products are used for antibody molecules analysis to identify and characterize proteins, antibody based biotherapeutics; monoclonal ant …
  • D. Western Therapeutics Institute Inc (4576):製薬・医療:M&Aディール及び事業提携情報
    Summary D. Western Therapeutics Institute Inc (DWTI) is a pharmaceutical product s developer. The company offers ophthalmic solution, WP-1303, H-1337, K-134 and DW-1002. It discovers and develops drugs for glaucoma. DWTI’s ophthalmic solution treats glaucoma and ocular hypertension treatment and art …
  • Eckert & Ziegler BEBIG SA (EZBG):医療機器:M&Aディール及び事業提携情報
    Summary Eckert & Ziegler BEBIG SA (Eckert & Ziegler), a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG is a medical device company that produces and distributes brachytherapy and radiotherapy products. The company offers products such as permanent prostate implants, HDR afterloaders, …
  • Akonni Biosystems Inc-医療機器分野:企業M&A・提携分析
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company’s products include nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray readers and …
  • ERG Renew SpA:電力:M&Aディール及び事業提携情報
    Summary ERG Renew S.p.A. (ERG Renew), formerly Entad S.p.A., a subsidiary of ERG S.p.A, is a power company that generates electricity from renewable sources. The company generates electricity mainly through wind. ERG Renew and its subsidiaries operate in Italy, France, Bulgaria/Romania, Germany, and …
  • Fate Therapeutics Inc (FATE)-製薬・医療分野:企業M&A・提携分析
    Summary Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company’s pipeline product candidates include cellular immunotherapy pipeline, immuno-oncology candidates, and immuno-regulatory candidate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆